TY  - GEN
AU  - Koulaouzidis,Anastasios
AU  - Marlicz,Wojciech
AU  - Koulaouzidis,Anastasios
AU  - Marlicz,Wojciech
TI  - Diagnosis and Treatment of Small Bowel Disorders
SN  - books978-3-03943-874-7
PY  - 2021///
CY  - Basel, Switzerland
PB  - MDPI - Multidisciplinary Digital Publishing Institute
KW  - Research & information: general
KW  - bicssc
KW  - Biology, life sciences
KW  - capsule endoscopy
KW  - Crohn’s disease
KW  - mucosal healing
KW  - small bowel
KW  - gut brain axis
KW  - microbiota
KW  - functional gastrointestinal disorders
KW  - inflammatory bowel disease (IBD)
KW  - adult stem cells
KW  - surgical site infections (SSIs)
KW  - probiotics
KW  - prebiotics
KW  - synbiotics
KW  - surgery
KW  - adverse events
KW  - meta-analysis
KW  - systematic review
KW  - hyperspectral imaging
KW  - multispectral imaging
KW  - clinical diagnosis
KW  - biomedical optical imaging
KW  - gastroenterology
KW  - medical diagnostic imaging
KW  - small-bowel mass
KW  - small-bowel bulge
KW  - video capsule endoscopy
KW  - cystic fibrosis
KW  - gut microbiota
KW  - intestinal inflammation
KW  - fecal calprotectin
KW  - dysbiosis index
KW  - celiac disease
KW  - biomarker
KW  - serology
KW  - enteropathy
KW  - n/a
KW  - colon cancer
KW  - cancer risk
KW  - collagenous colitis
KW  - lung cancer
KW  - microscopic colitis
KW  - skin cancer
KW  - squamous cell carcinoma
N1  - Open Access
N2  - Over the last few decades, remarkable progress has been made in understanding the aetiology and pathophysiology of diseases and many new theories emphasize the importance of the small bowel ‘ecosystem’ in the pathogenesis of acute and chronic illness. Emerging factors such as microbiome, stem cells, innate intestinal immunity and the enteric nervous system along with mucosal and endothelial barriers have key role in the development of gastrointestinal and extra-intestinal diseases. Therefore, the small intestine is considered key player in metabolic disease development, including diabetes mellitus, and other diet-related disorders such as celiac and non-celiac enteropathies. Another major field is drug metabolism and its interaction with microbiota. Moreover, the emergence of gut-brain, gut-liver and gut-blood barriers points toward the important role of small intestine in the pathogenesis of common disorders, such as liver disease, hypertension and neurodegenerative disease. However, the small bowel remains an organ that is difficult to fully access and assess and accurate diagnosis often poses a clinical challenge. Eventually, the therapeutic potential remains untapped. Therefore, it is due time to direct our interest towards the small intestine and unravel the interplay between small-bowel and other gastrointestinal (GI) and non-GI related maladies
UR  - https://mdpi.com/books/pdfview/book/3353
UR  - https://directory.doabooks.org/handle/20.500.12854/68343
ER  -